Sail driving for global expansion and scale

TORONTO, July 11, 2018 /CNW/ - Cannabis Growth Opportunity Corporation (CSE: CGOC) today announced an investment in Sail Cannabis (Sail), a secure cloud-based cannabis healthcare decision making platform serving clinicians and patients. The deal demonstrates CGOC's approach to leveraging its early mover advantage to access investments in high growth global companies.

Sail is an established healthcare technology company with a solid international presence, proven revenue model and positive cash flow from operations. The Sail platform offers knowledge translation and evidence-based data delivered through technology to support decisions at the point of care. Operating in over 14 markets across the globe, Sail has supported over 250,000 patients in their healthcare journeys with cannabis to date. The company plans to expand into Australia, Germany, Columbia and others in the next two years.

"We aim to give our shareholders the one-of-a-kind expertise and focus needed to grow investments in this unique market and this unique deal is an example of funding a private company poised to lead in its category," says Jamie Blundell, President and COO of CGOC. "As more and more clinicians and patients learn about the medicinal and pharmaceutical benefits of cannabis, we expect Sail's platform to provide the much-needed education and information to help them make informed decisions on qualification, dosing and prescriptions."

CGOC invested $400,000 for 176,000 common share units of Sail.

Pradyum Sekar, Sail's CEO and Co-Founder says, "our goal is to break down the barriers between patients and the doctors who are willing to help them by providing access to educated physicians, education centers, and data support tools that can help patients make more informed decisions. Partners like CGOC are pivotal in our ability to help meet this increasing need around the world."

About Sail Cannabis

Sail's mission is to simplify the medical cannabis journey through a suite of healthcare technology products and solutions such as its HIPAA and PHIPA compliant Clinical Decision Support platform, patient engagement tools and clinical research group. Sail's solutions work to close the knowledge gap between physicians, patients, distributors, wholesalers and other key stakeholders within the medical cannabis ecosystem. Sail is a subsidiary of MVC Technologies Inc. Learn more at www.sailcannabis.co.

About Cannabis Growth Opportunity Corporation

CGOC is a unique investment corporation incorporated under the laws of Canada. CGOC's investment objectives are to provide holders of common shares long-term total return through capital appreciation by investing in an actively managed portfolio of securities of public and private companies operating in, or that derive a portion of their revenue or earnings from, products or services related to the cannabis industry. http://cgocorp.com/. To access the company's July webinar, please visit http://cgocorp.com/investors/ and take the time to register for the news feed.

This press release is not an offer of securities for sale in the United States, and the securities described in this press release may not be offered or sold in the United States absent registration or an exemption from registration. The securities have not been and will not be registered under the United States Securities Act of 1933.

SOURCE Cannabis Growth Opportunity Corporation

For further information: Jamie Blundell, President and Chief Operating Officer, Cannabis Growth Opportunity Corporation, 647-946-2205, [email protected]